GH
TTPH

GAM Holding’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

GAM Holding’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-596
Closed -$37K – 995
2018
Q1 		$37K Buy
+596
New +$52.3K ﹤0.01% 809

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GAM Holding's TTPH Position: Q2 2018 in Review

GAM Holding sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2018, closing a stake of 596 shares — an estimated $37K sold.

GAM Holding first reported a position in TTPH in Q1 2018 and held it in 1 quarter. The position peaked at $37K in Q1 2018. 90 funds tracked by Wall St. Rank hold TTPH as of Q2 2018.

  • GAM Holding reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • GAM Holding sold 596 Tetraphase Pharmaceuticals, Inc. shares in Q2 2018, an estimated $37K.
  • GAM Holding first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2018 and held it in 1 quarter.
  • GAM Holding's Tetraphase Pharmaceuticals, Inc. position peaked at $37K in Q1 2018.
  • 90 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2018.

Based on GAM Holding's 13F filing for Q2 2018, filed 9 Aug 2018.